Patent · US Expired

.alpha.-Glucosidase inhibiting 2-hydroxymethyl-3,4,5-trihydroxy-piperidines

US4328233A · kind A · utility

10Cited by

2References

22Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Horst Boshagen · Haan, DE
Rudiger Sitt · Wuppertal, DE
Ernst Truscheit · Häger, DE

Key dates

Filing date	Oct 29, 1979
Grant date	May 4, 1982
Priority date	—
Expiry date	Oct 29, 1999

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to 2-hydroxymethyl-3,4,5-trihydroxy-6-substituted-piperidines and methods for their preparation. The invention also includes compositions containing said 2-hydroxymethyl-3,4,5-trihydroxy-6-substituted-piperidines and the use of said compounds and compositions for influencing carbohydrate metabolism and fat metabolism and for use in animal nutrition as feed additives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.